previous compound ID: 282 next compound
InChIKey: BTIHMVBBUGXLCJ-OAHLLOKOSA-N
SMILES: CC[C@H](CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "J Liao" "D Rotin" "JW Hanrahan" "SD Macknight" "B Kus" "R Robert" "GW Carlile" "J Goepp" "DY Thomas"

chemical graph of compound 282





CID is 160355
synonyms found at PubChem are:
roscovitine, Seliciclib, 186692-46-6, R-Roscovitine, (R)-roscovitine, CYC202, CYC-202, CYC 202, Rosco, 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine, UNII-0ES1C2KQ94, NSC 701554, AL-39256, InSolution™ Roscovitine, CHEMBL14762, 0ES1C2KQ94, BMK1-E12, CHEBI:45307, Roscovitine (Seliciclib,CYC202), (2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol, NSC701554, NSC-701554, (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol, (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol, (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol, (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol, M02443, RRC, C19H26N6O, 6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine, (2R)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol, 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol, Seliciclib [INN], CYC202, Seliciclib, R-roscovitine, Roscovitine, 1unl, 3ddq, (2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol, 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol, Roscovitine/CYC202, 2a4l, BiomolKI_000048, 1-Butanol, (2R)-, ROSCOVITINE(Seliciclib), BiomolKI2_000054, D02TIZ, D05ADP, AC1L4NH4, AC1Q4VI5, CBiol_002016, Lopac0_001102, SCHEMBL94728, BSPBio_001078, KBioGR_000418, KBioSS_000418, MLS006011028, BDBM7533, cid_160355, GTPL6035, Roscovitine, >=98% (TLC), BCBcMAP01_000013, CTK4D9313, KBio2_000418, KBio2_002986, KBio2_005554, KBio3_000795, KBio3_000796, AOB2095, DTXSID20171928, EX-A052, BTIHMVBBUGXLCJ-OAHLLOKOSA-N, MolPort-003-959-463, BCPP000087, Bio1_000302, Bio1_000791, Bio1_001280, Bio2_000379, Bio2_000859, CC205, HMS1362F19, HMS1792F19, HMS1990F19, HMS3229N13, HMS3403F19, BCP01760, Roscovitine (Seliciclib, CYC202), ZINC1649340, ABP000228, BS0304, GP3424, HSCI1_000092, MFCD02266401, s1153, AKOS005146319, AC-2416, AN-1311, CCG-100652, RL02372, IDI1_002134, SMP1_000266, 2,6,9-Trisubstituted purine deriv. 28, NCGC00094374-01, NCGC00094374-02, NCGC00094374-03, NCGC00094374-04, NCGC00094374-05, AJ-28787, BC683378, HY-30237, KB-60358, NCI60_036420, SC-85946, SMR004702823, AB1010069, CYC202, Seliciclib, 186692-46-6, LS-182554, RT-015440, FT-0674460, X7381, K00020, S-7720, 692R466, J-011999, J-524224, BRD-K07691486-001-03-1, BRD-K07691486-001-05-6, UNII-AIR55KO85E component BTIHMVBBUGXLCJ-OAHLLOKOSA-N, (2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol, (2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol, (2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol, (R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (2R)-, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (R)-, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (2R)-, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (R)-, 1-Butanol,2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-, 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol, 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol; 6-(Benzylamino) -2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine, Seliciclib|||CYC-202|||(2R)-2-[[6-(Benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol